US Patent Issued to BioGaia on June 2 for "Selection and use of melatonin supporting bacteria to reduce infantile colic" (Swedish Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,830, issued on June 2, was assigned to BioGaia AB (Stockholm).

"Selection and use of melatonin supporting bacteria to reduce infantile colic" was invented by Stefan Roos (Uppsala, Sweden) and Bo Mollstam (Lerum, Sweden).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to lactic acid bacterial strains which are capable of producing or inducing the production of melatonin, for use in the production of melatonin in a subject. Preferred strains for such uses are capable of producing or inducing the production of adenosine. Therapeutic uses of such strains include the treatment or prevention of diseases associated with melatonin...